Across TCGA patient cohorts, RNU6-321P RNA expression is significantly associated with the go_rna of many other GO terms, with 6,237 significant associations in total. STAD shows the largest number of these associations.

The most reproducible RNU6-321P-associated GO terms across cancer lineages are Peptidyl-lysine modification, Transcription by RNA polymerase III, and Positive regulation of post-translational protein modification. Each is linked with RNU6-321P in more than 9 cancer types. Because this analysis shows association rather than direction, both RNU6-321P-to-partner and partner-to-RNU6-321P results are reported.

Each partner links to its own Q-omics profile.

RNA expression associated GO terms by consensus

Ranked by combined sampling and lineage consensus. X-score (RNU6-321P→partner) and Y-score (partner→RNU6-321P) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner GO term	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
LUSC	Peptidyl-lysine modification →	+0.114	+0.048	<.001	.007	2	10
ESCA	Transcription by RNA polymerase III →	+0.106	+0.113	<.001	.001	3	8
ESCA	Positive regulation of post-translational protein modification →	+0.113	+0.191	<.001	<.001	3	8
ESCA	Regulation of DNA strand elongation →	+0.102	+0.219	<.001	<.001	3	8
STAD	Regulation of pattern recognition receptor signaling pathway →	+0.078	+0.186	<.001	<.001	3	8
ESCA	DNA-templated transcription elongation →	+0.116	+0.124	<.001	<.001	3	8

Each partner links to its Q-omics profile. Showing the 6 strongest of 6,237 associations by consensus.

Exploration

RNU6-321P survival (RNA) · tumor vs normal (RNA) · all RNU6-321P data types